Endotoxin induces increased intracellular cathepsin B activity in THP-1 cells

Immunopharmacology and Immunotoxicology

Volumn 19, Issue 2, 1997, Pages 215-237

  Li, Qingdi ^a,c   Falkler Jr , William A ^a   Bever Jr , Christopher T ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UMH   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN B; GAMMA INTERFERON; LIPOPOLYSACCHARIDE; MESSENGER RNA; RECOMBINANT GAMMA INTERFERON;

ARTICLE; HUMAN; HUMAN CELL; INFLAMMATION; MACROPHAGE; PRIORITY JOURNAL; TUMOR CELL;

EID: 0030896040     PISSN: 08923973     EISSN: None     Source Type: Journal    
DOI: 10.3109/08923979709007660     Document Type: Article

References (61)

1. Page RC and Schroeder HE. Periodontitis in Man and Other Animals. A Comparative Review, p. 17-57, 222-263, Karger, Basel, 1982.
2. Slots J. Subgingival microflora and periodontal disease. J. Clin. Periodontal., 6:351-382, 1979.
3. Williams R. Medical progress: periodontal disease. N. Engl. J. Med., 322:373-382, 1990.
4. Cimasoni G. Crevicular fluid updated. In monographs in oral sciences, edited by Myers HM, p. 1-152, Karger, Basel, 1983.
5. Kunimatsu K, Yamamoto K, Ichimaru E, Kato Y and Kato I. Cathepsin B, H and L activities in gingival crevicular fluid from chronic adult periodontitis patients and experimental gingivitis subjects. J. Periodont. Res., 25:69-73, 1990.
6. Trabant A, Muller-Ladner U, Kriegsmann J, Gay RE and Gay S. Expression of proteolytic cathepsin B, D and L in periodontal gingival fibroblasts and tissues. Lab. Invest., 73:205-212, 1995.
7. Lah T, Skaleric U, Babnik J and Turk V. Cathepsin B, D and L in inflamed human gingiva. J. Periodont. Res., 20:458-466, 1985.
8. Etherington DJ and Evans PJ. The action of cathepsin B and collagenolytic cathepsin in the degradation of collagen. Acta Biol. Med. Ger., 36:1555-1563, 1977.
9. Cardozo C, kurtz C and Lesser M. Degradation of rat lung collagens by cathepsin B. J. Lab. Clin. Med., 119:169-175, 1992.
10. Barrett AJ and Kirschke H. Cathepsin B, cathepsin H, and cathepsin L. Methods of Enzymol., 80:535-561, 1981.
11. Etherington DJ. Proteinases in connective tissue breakdown. Excerpta Medica, 75:87-103, 1980.
12. Lah TT, Buck MR, Honn KV, et al. Degradation of laminin by human tomor cathepsin B. Clin. Exp. Metastasis, 7:461-468, 1989.
13. Adams DO and Hamilton TA. The cell biology of macrophage activation. Ann. Rev. Immunol., 2:283-318, 1984.
14. Adams DO and Hamilton TA. Molecular transductional mechanisms by which IFN-γ and other signals regulate macrophage development. Immunol. Rev., 97:5, 1987.
15. Hamilton TA. Molecular mechanisms in the activation of mononuclear phagocytes. In immunopharmacology, edited by Rogers TJ and Gilman SC, p. 213, Telford Press, New Jersey, 1988.
16. Rietschel ET and Brade H. Bacterial endotoxins. Sci. Amer., 267:54, 1992.
17. Tsuchiya S, Yamabe M, Yamaguchi Y, Kobayashi Y, Konno T and Tada K. Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int. J. Cancer, 26:171-176, 1980.
18. Bever CT, Snyder DS, Endres RO, Morgan KD, Postlethwaite A and Whitaker JN. Activation of astrocytic lysosomal proteinases by factors released by mononuclear leukocytes. Neurochem. Res., 14:37-41, 1989.
19. Chomczynski P and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162:156-159, 1987.
20. Sambrook J, Fritsch EF and Maniatis T. Molecular Cloning: A laboratory Manual.Cold Spring Harbor, NY: Cold Spring Harbor, 1989.
21. Cieri M and Bever CT. Gamma interferon induced increases in cathepsin B activity are blocked by alpha and beta interferons (Type I interferon). FASEB J., 4:A339, 1990.
22. Page R. The role of inflammatory mediators in the pathogenesis of periodontal disease. J. Periodont. Dis., 26:230-242, 1991.
23. Klausen B, Evans R, Nangavaram S, Ramamurthy N, Golub L and Sfintescu C. Periodontal bone loss and gingival proteinase activity in gnotobiotic rats immunized with Bacteroides gingivalis. Oral Microbiol. Immunol., 6:193-201, 1991.
24. Sodek J, Overall C. Matrix metalloproteinases in periodontal tissue remodeling. Matrix, 1(Suppl):352-362, 1992.
25. Birkedal-Hansen H, Moore G, Bodden M, Windsor L, Birkedal-Hansen B and DeCarlo A. Matrix metalloproteinases. Crit. Rev. Oral Biol. Med., 4:197-250, 1993.
26. Eeckhout Y and Vaes G. Further studies on the activation of procollagenase, the latent precursor of bone collagenase: effects of lysosomal cathepsin B, plasmin and kallikrein, and spontaneous activation. Biochem. J., 166:21-31, 1977.
27. Dalet-Fumeron V, Guinec N and Pagano M. In vitro activation of procathepsin B by three serine proteases: leucocyte elastase, cathepsin G, and the urokinase-type plasminogen activator. FEBS Lett., 332:251-254, 1993.
28. Unemori E and Werb Z. Collagenase expression and endogenous activation in rabbit synovial fibroblasts stimulated by the calcium ionophore A23187. J. Biol. Chem., 31:16252-16259, 1988.
29. Tanaka K, Ikegaki N and Ichihara A. Effects of leupeptin and pepstatin on protein turnover in adult rat hepatocytes in primary culture. Arch. Biochem. Biophys., 208:296-304, 1981.
30. Maciewicz R and Wotton S. Degradation of cartilage matrix components by the cysteine proteinases, Cathepsin B and L. Biomed. Biochim. Acta, 50:561-564, 1991.
31. Nguyen Q, Mort J and Roughley P. Cartilage proteoglycan is degradated more extensively by cathepsin L than cathepsin B. Biochem. J., 66:569-573, 1992.
32. Mizuochi T, Yee ST, Kasai M, Kakiuchi T, Muno D and Kominami E. Both cathepsin B and cathepsin D are necessary for processing of ovalbumin as well as for degradation of class II MHC invariant Chain. Immunol. Lett., 43:189-193, 1994.
33. Reyes VE, Lu S and Humphreys RE. Cathepsin B cleavage of Ii from class II MHC alpha- and beta-chains. J. Immunol., 146:3877-3880, 1991.
34. Roche PA and Cresswell P. Proteolysis of the class II associated invariant chain generates a peptide binding site in intracellular HLA-DR molecules. Proc. Natl. Acad. Sci. U. S. A., 88:3150-3154, 1991.
35. Daibata M, Xu M, Humphreys RE and Reyes VE. More efficient peptide binding to MHC class II molecules during cathepsin B digestion of Ii than after Ii release. Mol. Immunol., 31:255-260, 1994.
36. Matsunaga Y, Saibara T, Kido H and Katunuma N. Participation of cathepsin B in processing of antigen presentation to MHC class II. FEBS Lett., 324:325-330, 1993.
37. Jonsson R, Pitts A, Lue C, Gay S and Mestecky J. Immunoglobulin isotype distribution of locally produced autoantibodies to collagen type I in adult periodontitis: relationship to periodontal treatment. J. Clin. Periodont., 18:703-707, 1991.
38. Cox S and Eley B. Detection of cathepsin B- and L-, elastase-, tryptase-, trypsin-, and dipeptidyl peptidase IV-like activities in crevicular fluid from gingivitis and periodontitis patients with peptidyl derivatives of 7-amino-4-trifluoromethyl coumarin. J. Periodont. Res., 24:353-361, 1989.
39. Eley B and Cox S. Correlation of gingival crevicular fluid proteases with clinical and radiological measurements of periodontal attachment loss. J. Dent., 20:90-99, 1992.
40. Vaes G. Cellular biology and biochemical mechanism of bone resorption. A review of recent developments on the formation, activation and mode of action of osteoclasts. Clin. Ortho. Rel. Res., 231:239-271, 1988.
41. Eley B and Cox S. Cathepsin B and L-like activities at local gingival tissue sites of chronic periodontitis patients. J. Clin. Periodontol., 18:499-504, 1991.
42. Morrison DC and Ryan JL. Bacterial endotoxins and host immune responses. Adv. Immunol., 28:293-450, 1979.
43. Pabst MJ and Johnston RB. Bacterial lipopolysaccharide: a mediator of inflammation, in Handbook of Inflammation, edited by Henson PM and Murphy RC, p. 361-393, Elsevier, New York, 1989.
44. Morrison DC and Ryan JL. Endotoxins and disease mechanisms. Annu. Rev. Med., 38:417-432, 1987.
45. Lesser M, Chang JC and Orlowski M. Cathepsin B and D activity in stimulated peritoneal macrophages. Mol. Cell. Biochem., 69:67-73, 1985.
46. Morland B. Cathepsin B activity in human blood monocytes during differentiation in vitro. Scand. J. Immunol., 22:9-16, 1985.
47. Ward CJ, Crocker J, Chan SJ, Stockley RA and Burnett D. Changes in the expression of elastase and cathepsin B with differentiation of U937 promonocytes by GMCSF. Biochem. Biophys. Res. Commun., 167:659-664, 1990.
48. Taylor JL and Grossberg SE. Recent progress in interferon research: molecular mechanism of regulation, action and virus circumvention. Virus Res., 15:1-26, 1990.
49. Baron S, Dianzani F, Stanton GJ and Fleischmann WR. The interferon system: a current review to 1987, University of Texas, Austin, TX, 1987.
50. Dianzani F and Antonelli G. Physiological mechanism of production and action of interferons in response to viral infections. Adv. Exp. Med. Biol., 257:47-60, 1989.
51. Nelson BE and Borden EC. Interferons: biological and clinical effects. Semin. Surg. Oncol., 5:391-401, 1989.
52. Baron S, Coppenhaver DH, Dianzani F, et al. Introduction to the interferon system; interferon-principles and medical applications, University of Texas, Galveston, TX, 1992.
53. Cooper SM, Sriram S and Ranges GE. Suppression of murine collagen-induced arthritis with monoclonal anti-Ia antibodies and augmentation with IFN-γ. J. Immunol., 141:1958, 1988.
54. Jacob CO, Holoshitz J, van der Meide P, Strober S and McDevitt HO. Heterogenous effects of interferon-γ in adjuvant arthritis. J. Immunol., 142:1500, 1989.
55. Gaffney EV, Lingenfelter SE, Koch GA, Lisi PJ, Chu CW and Tsai SC. Regulation by interferon-γ of function in the acute monocytic leukemia cell line, THP-1. J. Leukocyte Biol., 43:248-255, 1988.
56. Harris PE, Ralph P, Litcofsky P and Moore MA. Distinct activities of interferon-γ, lymphokine, and cytokine differentiation-inducing factors acting on the human monoblastic leukemia cell line U937. Cancer Res., 45:9, 1985.
57. Qian F, Chan SJ, Achkar C, Steiner DF and Frankfater A. Transcriptional regulation of cathepsin B expression in B16 melanomas of varying metastatic potential. Biochem. Biophys. Res. Commun., 202:429-436, 1994.
58. Sloane BF, Moin K, Krepela E and Rozhin J. Cathepsin B and its endogenous inhibitors: the role in tumor malignancy. Cancer and Metastasis Reviews, 9:333-352, 1990.
59. Rao NK, Shi GP and Chapman HA. Urokinase receptor is a multifunctional protein: influence of receptor occupancy on macrophage gene expression. J. Clin. Invest., 96:465-474, 1995.
60. Keppler D, Waridel P, Abrahamson M, Bachmann D, Berdoz J and Sordat B. Latency of cathepsin B secreted by human colon carcinoma cells is not linked to secretion of cystatin C and is relieved by neutrophil elastase. Biochim. Biophys. Acta, 1226:117-125, 1994.
61. Burnett D, Abrahamson M, Devalia JL, Sapsford RJ, Davies RJ and Buttle DJ. Synthesis and secretion of procathepsin B and cystatin C by human bronchial epithelial cells in vitro: modulation of cathepsin B activity by nertrophil elastase. Arch. Biochem. Biophys., 317:305-310, 1995.